Trade AbbVie ^ABBV

High Yield vs. Sustainable Growth: Why AbbVie's Dividend Beats Pfizer's Despite the Lower Payout - 24/7 Wall St.

9 Newly Overvalued Stocks this Week | Morningstar

Trueblood Wealth Management LLC Buys 2,793 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie forecasts $744M hit from drug pipeline costs

Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com

ABBVIE SP. Z O.O. secures contract for Various medicinal products

Analysts' Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) | Markets Insider

Clipping a 12% Coupon on a Big Pharma Name

AbbVie Inc. $ABBV Shares Purchased by Kelleher Financial Advisors

AbbVie Inc. $ABBV Shares Purchased by JB Capital LLC

AbbVie Inc. $ABBV is Advocate Group LLC's 4th Largest Position

Kelleher Financial Advisors Boosts Stock Position in AbbVie Inc. $ABBV - Daily Political

Toth Financial Advisory Corp Buys 3,300 Shares of AbbVie Inc. $ABBV - Stock Observer

Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily

How Investors Are Reacting To AbbVie (ABBV) Dermatology Data, Governance Debate and Rising Tariff Risk

Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative

Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer

Sensor-based digital health technologies to capture endpoints in recent clinical trials: a scoping review

ABBVIE SP. ZO.O. secures contract for Pharmaceutical products, Pharmaceutical products

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

AbbVie (NYSE:ABBV) Stock Price Up 2% - Here's What Happened - Daily Political

Best Pharmaceutical Stocks To Follow Now - April 2nd - Daily Political

Tema Etfs LLC Raises Stock Holdings in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Shares Sold by Trust Co. of Vermont

Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update

Compagnie Lombard Odier SCmA Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Holdings Trimmed by Trust Co. of Vermont - Daily Political

Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensus

AbbVie (NYSE:ABBV) Shares Down 1.3% - Time to Sell?

Is It Too Late To Consider AbbVie (ABBV) After Its Recent Share Price Swings?

AbbVie (NYSE:ABBV) Shares Up 1.8% - Here's Why - Stock Observer

Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV

Capital Advisors Inc. OK Raises Stake in AbbVie Inc. $ABBV

Nisa Investment Advisors LLC Acquires 204,761 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC

AbbVie Inc. $ABBV Stock Holdings Trimmed by Vaughan Nelson Investment Management L.P. - Daily Political

AbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?

Pharmaceutical Stocks To Watch Today - March 31st

AbbVie Leans Into Consumer Aesthetics With CoolMonth And Neurotoxin Pipeline

Ovarian Cancer Drugs Market Outlook Report 2026-2030 Featuring Strategic Analysis of AstraZeneca, Roche, Bristol-Myers Squibb Company, Clovis Oncology, Pfizer and Other Key Players

Range Financial Group LLC Has $1.08 Million Stock Holdings in AbbVie Inc. $ABBV

Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®

AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V.

Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - Stock Observer

J. Safra Sarasin Holding AG Has $71.14 Million Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Stock Price Up 1.8% - Should You Buy?

Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD) | Morningstar

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

AbbVie Inc. $ABBV Stock Position Raised by TrueMark Investments LLC

AbbVie Inc. $ABBV Shares Acquired by Stegent Equity Advisors Inc.

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

TrueMark Investments LLC Acquires 4,878 Shares of AbbVie Inc. $ABBV - Stock Observer

Assessing AbbVie (ABBV) Valuation After New Dermatology Data Underpins Immunology Growth Potential

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Infographic: teprotumumab for the treatment of active thyroid eye disease

AbbVie Inc. $ABBV Stock Holdings Lifted by Waycross Partners LLC

Top Pharmaceutical Stocks To Follow Now - March 29th - Daily Political

Bell Bank Has $12.09 Million Stake in AbbVie Inc. $ABBV

AbbVie Dermatology Data Sparks Questions On Growth Potential And Valuation

AbbVie Dermatology Data Highlights Immunology Depth And Emerging Skin Disease Opportunities

Wealthcare Advisory Partners LLC Grows Stake in AbbVie Inc. $ABBV

Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily

TABR Capital Management LLC Takes Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Capital Investment Advisors LLC

Hourglass Capital LLC Sells 3,960 Shares of AbbVie Inc. $ABBV - Stock Observer

Generate Investment Management Ltd Sells 49,224 Shares of AbbVie Inc. $ABBV - Stock Observer

Exchange Traded Concepts LLC Grows Holdings in AbbVie Inc. $ABBV - Stock Observer

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

AbbVie call volume above normal and directionally bullish | Markets Insider

AbbVie to Highlight New Clinical and Real-World Evidence Adv

AbbVie Inc. $ABBV Shares Bought by World Investment Advisors - Markets Daily

World Investment Advisors Increases Position in AbbVie Inc. $ABBV

3 Stocks That May Be Underestimated In March 2026

Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends - AOL

Dakota Wealth Management Raises Position in AbbVie Inc. $ABBV

Global X Japan Co. Ltd. Increases Stock Position in AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Trading 1.9% Higher - Time to Buy?

Independent Chair Push Tests AbbVie Governance And Valuation Expectations

AbbVie (NYSE:ABBV) Trading Up 1.9% - Here's What Happened - Daily Political

AbbVie FY2027 EPS Estimate Increased by Erste Group Bank

Czech National Bank Purchases 17,373 Shares of AbbVie Inc. $ABBV

Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC) | Morningstar

Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (

Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial

MediaPost Publications - Marketing Daily 03/26/2026

Is AbbVie (ABBV) Now Offering Value After Recent Share Price Weakness?

VIG Returned 223% Over 10 Years and Still Costs Almost Nothing

Pensionfund Sabic Invests $4.02 Million in AbbVie Inc. $ABBV

Top Pharmaceutical Stocks To Watch Today - March 25th - Daily Political

Meadowbrook Wealth Management LLC Grows Stake in AbbVie Inc. $ABBV

DAVENPORT & Co LLC Sells 5,545 Shares of AbbVie Inc. $ABBV

62,112 Shares in AbbVie Inc. $ABBV Bought by E. Ohman J or Asset Management AB

AbbVie Inc. $ABBV is Bill Few Associates Inc.'s 7th Largest Position

AbbVie's MLB Cancer Push And Psychedelic Bet Versus Lofty Valuation

Is AbbVie (ABBV) one of the Best Psychedelic Stocks to Buy in 2026?